In this study, we conducted a comparative molecular and functional study of Caco2 colorectal cancer cell clones with individual knockouts of either CD133, a widely used CSC surface marker [5,9], or TRIM28, an epigenetic regulator previously shown to modulate CD133 expression [15]. The gene discussed is TRIM28; the disease is colorectal cancer.